Kontigo Care AB (publ)

Stockholm Stock Exchange KONT.ST

Kontigo Care AB (publ) Price to Sales Ratio (P/S) on February 03, 2025: 2.71

Kontigo Care AB (publ) Price to Sales Ratio (P/S) is 2.71 on February 03, 2025, a 22.29% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Kontigo Care AB (publ) 52-week high Price to Sales Ratio (P/S) is 3.93 on October 30, 2024, which is 44.65% above the current Price to Sales Ratio (P/S).
Kontigo Care AB (publ) 52-week low Price to Sales Ratio (P/S) is 1.83 on March 04, 2024, which is -32.64% below the current Price to Sales Ratio (P/S).
Kontigo Care AB (publ) average Price to Sales Ratio (P/S) for the last 52 weeks is 2.52.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

Stockholm Stock Exchange: KONT.ST

Kontigo Care AB (publ)

CEO	Ms. Ulrika Giers
IPO Date	June 23, 2015
Location	Sweden
Headquarters	PAvel Snickares GrAend 12
Employees	12
Sector	Healthcare
Industries Mental Health Augmented Reality (AR) Biotechnology Casinos Drugstores & Retail Pharmacies Fintech Pharmaceuticals Telehealth

Description

Kontigo Care AB (publ) provides health care solutions for addiction treatment in Sweden. It offers Previct Alcohol, a digital medical device for the treatment of alcohol dependence; and Previct Gambling, a digital tool for the treatment of gambling addiction. The company was incorporated in 2013 and is headquartered in Uppsala, Sweden.

Key trends

Past 5 years